SpaceX Files for IPO
SpaceX filed paperwork for a U.S. stock-market debut under ticker SPCX. The planned offering could value the company above $1 trillion and push Elon Musk's net worth past that mark.
news.google.comU.S. markets that would list the company under the ticker SPCX. 25 trillion, and Musk's majority stake could be worth more than $600 billion. 9 billion. 3 billion. 5 billion in debt.
SpaceX flagged more than $500 million in expected legal costs tied to ongoing lawsuits. The cases include allegations that the Grok chatbot created by xAI generated sexualized deepfakes, patent disputes, EU content-moderation claims, music copyright issues, and data-breach complaints.
The filing also disclosed terms of a recent agreement under which Anthropic will pay $15 billion annually to use data centers in the American South for xAI operations.
The IPO filing came days after a jury rejected Musk's lawsuit against OpenAI and its chief executive Sam Altman. The court found the claims were filed after the allowed timeframe. Musk has stated he plans to fold xAI into SpaceX and continue AI work under the larger company.
SpaceX also owns the social-media platform X, which Musk acquired in 2022. " — Ruth Foxe-Blader, managing partner at Citrine Venture Partners SpaceX's Starship rocket is scheduled for a launch this week. The company has faced separate scrutiny over worker safety at its facilities.
Key Facts
Story Timeline
3 events- 2 days ago
SpaceX filed IPO documents listing the company under ticker SPCX.
3 sourcesBBC · bbc.co.uk · BBC News - Last week
Musk traveled to China with President Trump.
1 sourceBBC News - Recent days
Jury dismissed Musk's lawsuit against OpenAI and Sam Altman.
1 sourceBBC News
Potential Impact
- 01
SpaceX shares will become available for public trading under ticker SPCX.
- 02
Musk's net worth could exceed $1 trillion if the IPO proceeds at the stated valuation.
- 03
SpaceX will face more than $500 million in anticipated legal expenses.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.